The Latest Breaking News from Stock Market

The Fed announced its fourth consecutive 75-basis-point interest rate increase yesterday and indicated that it could raise interest rates higher than expected. This is expected to keep the stock market under pressure in the upcoming months. Therefore, we think losing ETFs Ark Innovation (ARKK) and SPDR S&P Biotech (XBI) are…

While the pandemic brought massive growth opportunities for the fintech industry as digital transactions skyrocketed, the current uncertain macroeconomic environment has dampened the industry’s prospects. The stock market is expected to remain under pressure amid growing fears of recession. Therefore, it could be wise for investors to avoid fundamentally weak…

A portfolio consisting of 60% stocks and 40% bonds had a golden age from the 1980s — until recently.The combination offers investors risk-adjusted returns that are frequently on par with, or greater to, those of the benchmark SP 500 Index.The 60/40 portfolio faced significant challenges this year due to ongoing…

Although the stock market has been under pressure this year due to macroeconomic headwinds, the pharmaceutical industry continues to garner investor attention as it enjoys inelastic demand for its products regardless of economic conditions. Thus, fundamentally-sound pharma stocks Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) could be worth your attention…